Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas

Miriam Potrony, Celia Badenas, Bénédicte Naerhuyzen, Paula Aguilera, Joan Anton Puig-Butille, Gemma Tell-Marti, Alba Díaz, Cristina Carrera, Llucia Alos, Nicolas Delahaye, Josep Malvehy, Susana Puig
  • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter
  • DOI: 10.1515/cclm-2015-1048

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Susana Puig

In partnership with: